BIOMAT Database Logo BIOMAT Database Logo

Attempted prophylaxis of human immunodeficiency virus type 1 infection in chimpanzees with a nonnucleoside reverse transcriptase inhibitor. 1994

W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Merck Research Laboratories, West Point, Pennsylvania 19486.

UI MeSH Term Description Entries
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002679 Pan troglodytes The common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies. Chimpanzee,Chimpanzee troglodytes,Chimpanzee troglodyte,Chimpanzees,Pan troglodyte,troglodyte, Pan,troglodytes, Chimpanzee
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001583 Benzoxazoles Benzoxazole
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.
December 2004, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase.
June 1997, Nature medicine,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor.
August 2002, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1.
October 2010, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.
February 2009, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Etravirine: A novel nonnucleoside reverse transcriptase inhibitor for managing human immunodeficiency virus infection.
February 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
July 2002, Journal of virology,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
May 1993, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
August 2006, Antimicrobial agents and chemotherapy,
W A Schleif, and K K Murthy, and V V Sardana, and C L Schneider, and V W Byrnes, and K E Cobb, and E Roth, and J A Wolfgang, and J M Hoffman, and A M Smith
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.
October 1995, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!